Effects of Improved Calf Muscle Function on Gait, Balance and Joint Loading in Older Adults

Sponsor
University of Eastern Finland (Other)
Overall Status
Suspended
CT.gov ID
NCT03921801
Collaborator
(none)
45
1
3
59.3
0.8

Study Details

Study Description

Brief Summary

This study investigates role of calf muscle function for gait performance, balance and knee joint loading.

Previous studies have linked age-related loss of calf muscle function with impairments in gait performance and balance, and increased loading of the areas of knee joint that are susceptible for development of osteoarthritis. In this study, an exercise intervention is used to target structural and neural aspects of impaired calf muscle function with aging. The intervention includes 14 weeks of strength training for the calf muscles and training sessions to enhance calf function during walking. The study will test whether the intervention is effective in improving walking speed, reduce metabolic cost of walking, improve standing balance and reduce knee joint loading.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Strength training + biofeedback
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
45 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Thirty older adults will be recruited and randomized into two groups. The other groups receive an intervention including strength training and gait retraining lasting for 14 weeks while the other group serves as a control group without receiving any intervention. At the end, outcome measures are obtained. A third group consists of 15 young adults. This group does not receive intervention and outcome measures are obtained only at a single time point.Thirty older adults will be recruited and randomized into two groups. The other groups receive an intervention including strength training and gait retraining lasting for 14 weeks while the other group serves as a control group without receiving any intervention. At the end, outcome measures are obtained. A third group consists of 15 young adults. This group does not receive intervention and outcome measures are obtained only at a single time point.
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Basic Science
Official Title:
Improving Plantarflexor Muscle Function to Alleviate Decline in Mobility, Loss of Balance and Detrimental Knee Joint Loading in Older Adults
Actual Study Start Date :
Dec 21, 2018
Anticipated Primary Completion Date :
Jan 1, 2023
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control

14-week control period.

Experimental: Intervention

14-week intervention. Intervention includes weekly gait retraining sessions with real-time electromyography biofeedback and home-based strength training session for plantarflexor muscles three times per week.

Behavioral: Strength training + biofeedback
Home based strength training intervention for plantarflexor muscles conducted three times per week for 14 weeks. In addition, gait retraining session using real-time electromyography biofeedback performed once per week.

No Intervention: Young adults - control

Outcome measures obtained at a single time point. The data is used to compare outcome measured between older and young adults.

Outcome Measures

Primary Outcome Measures

  1. Knee joint loading at baseline [At week 0]

    Knee joint loading during walking assessed at baseline. Estimated using musculoskeletal modeling and simulation.

  2. Knee joint loading at week 14 [At week 14]

    Knee joint loading during walking assessed at week 14. Estimated using musculoskeletal modeling and simulation.

  3. Maximal walking speed at baseline [At week 0]

    Maximal walking speed at baseline. Assessed using 10-meter walking trial.

  4. Maximal walking speed at week 14 [At week 14]

    Maximal walking speed at week 14. Assessed using 10-meter walking trial.

  5. Preferred walking speed at baseline [At week 0]

    Baseline preferred walking speed. Assessed using 10-meter walking trial

  6. Preferred walking speed at week 14 [At week 14]

    Preferred walking speed at week 14. Assessed using 10-meter walking trial

  7. Baseline walking economy [At week 0]

    Baseline metabolic energy cost required to travel unit distance. Measured during walking using indirect calorimetry.

  8. Walking economy at week 14 [At week 14]

    Metabolic energy cost required to travel unit distance at week 14. Measured during walking using indirect calorimetry.

  9. Baseline standing balance [At week 0]

    Baseline standing balance. Measured as center of pressure sway during eyes open and closed standing on a force plate.

  10. Standing balance at week 14 [At week 14]

    Standing balance at week 14. Measured as center of pressure sway during eyes open and closed standing on a force plate.

Secondary Outcome Measures

  1. Muscle strength [Up to week 14]

    Ankle plantarflexor muscle strength assessed using maximal isometric contractions.

  2. Triceps surae muscle morphology [At weeks 0 and 14]

    Triceps surae muscle cross-sectional area, volume and muscle architecture (fascicle length and pennation angle) measured using magnetic resonance imaging and ultrasound imaging.

  3. Achilles tendon stiffness [At weeks 0 and 14]

    Achilles tendon stiffness evaluated using combination of ultrasonography, motion analysis and force measurements.

  4. Walking mechanics [At weeks 0 and 14]

    Kinematic, kinetic and electromyographic description of walking mechanics measured using instrumented treadmill, motion capture system and electromyography measurements.

  5. Muscle-tendon function during walking [At weeks 0 and 14]

    Muscle fascicle kinematics measured using dynamics ultrasonography during walking.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • age between 65 and 75 (older adults) or 18 and 35 (young adults)
Exclusion Criteria:
  • dependent living status

  • not able walk without assistive device or 30 min without stopping

  • diagnosed neurological disease or joint disorder and pain during walking

  • surgery on lower extremities

  • current musculoskeletal injury

  • previous cardiovascular event or symptoms during exercise (acute ECG change, coronary disease, symptomatic arrhythmia, symptomatic coronary stenosis, heart failure, myocarditis, pericarditis, pulmonary embolism, pulmonary infarct, artery bulge or rupture risk)

  • body mass index <18 or >35 kg/m2

  • contraindications for magnetic resonance imaging

  • Mini Mental State Examination score of 23 points and lower

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Eastern Finland Kuopio North Savo Finland 70100

Sponsors and Collaborators

  • University of Eastern Finland

Investigators

  • Principal Investigator: Lauri Stenroth, PhD, University of Eastern Finland

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Lauri Stenroth, Senior Researcher, University of Eastern Finland
ClinicalTrials.gov Identifier:
NCT03921801
Other Study ID Numbers:
  • LS_Plantarflex
First Posted:
Apr 19, 2019
Last Update Posted:
May 24, 2021
Last Verified:
May 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Lauri Stenroth, Senior Researcher, University of Eastern Finland
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 24, 2021